Zee Learn Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:30 pm

Quick Insight

Zee Learn Ltd's current market capitalization stands at ₹322 Cr. with a P/E ratio of 15.8, indicating investor confidence in future earnings growth. The company's healthy Return on Equity (ROE) at 9.68% and Return on Capital Employed (ROCE) at 15.4% underscore efficient capital utilization. With a robust Operating Profit Margin (OPM) of 41%, Zee Learn demonstrates effective cost management. However, the firm's low Price-to-Book Value (P/BV) ratio of 0.91x suggests potential undervaluation in the market. Furthermore, the high level of borrowings at ₹399 Cr. raises concerns about leverage. Investors may consider monitoring Zee Learn's debt levels closely to assess financial stability and growth prospects effectively.

Competitors of Zee Learn Ltd

All Competitor Stocks of Zee Learn Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:16 am

Below is a detailed analysis of the quarterly data for Zee Learn Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Dec 2024) to 159.00 Cr., marking an increase of 84.00 Cr..
• For Expenses, as of Mar 2025, the value is 94.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 66.00 Cr. (Dec 2024) to 94.00 Cr., marking an increase of 28.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Dec 2024) to 65.00 Cr., marking an increase of 56.00 Cr..
• For OPM %, as of Mar 2025, the value is 41.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Dec 2024) to 41.00%, marking an increase of 30.00%.
• For Other Income, as of Mar 2025, the value is -12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Dec 2024) to -12.00 Cr., marking a decrease of 19.00 Cr..
• For Interest, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 10.00 Cr..
• For Depreciation, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.00 Cr. (Dec 2024) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Dec 2024) to 32.00 Cr., marking an increase of 35.00 Cr..
• For Tax %, as of Mar 2025, the value is 47.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Dec 2024) to 47.00%, marking an increase of 26.00%.
• For Net Profit, as of Mar 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from -4.00 Cr. (Dec 2024) to 17.00 Cr., marking an increase of 21.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.52. The value appears strong and on an upward trend. It has increased from -0.11 (Dec 2024) to 0.52, marking an increase of 0.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:23 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:03 pm

Below is a detailed analysis of the balance sheet data for Zee Learn Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
• For Reserves, as of Mar 2025, the value is 163.00 Cr.. The value appears strong and on an upward trend. It has increased from 150.00 Cr. (Mar 2024) to 163.00 Cr., marking an increase of 13.00 Cr..
• For Borrowings, as of Mar 2025, the value is 399.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 360.00 Cr. (Mar 2024) to 399.00 Cr., marking an increase of 39.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 915.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 542.00 Cr. (Mar 2024) to 915.00 Cr., marking an increase of 373.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,509.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,084.00 Cr. (Mar 2024) to 1,509.00 Cr., marking an increase of 425.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 616.00 Cr.. The value appears to be declining and may need further review. It has decreased from 628.00 Cr. (Mar 2024) to 616.00 Cr., marking a decrease of 12.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 888.00 Cr.. The value appears strong and on an upward trend. It has increased from 456.00 Cr. (Mar 2024) to 888.00 Cr., marking an increase of 432.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,509.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,084.00 Cr. (Mar 2024) to 1,509.00 Cr., marking an increase of 425.00 Cr..

However, the Borrowings (399.00 Cr.) are higher than the Reserves (163.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Zee Learn Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has decreased from 4.99 (Mar 24) to 0.39, marking a decrease of 4.60.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has decreased from 4.99 (Mar 24) to 0.39, marking a decrease of 4.60.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 3. It has decreased from 5.51 (Mar 24) to 1.50, marking a decrease of 4.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.00. It has increased from 5.60 (Mar 24) to 6.00, marking an increase of 0.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.00. It has increased from 5.60 (Mar 24) to 6.00, marking an increase of 0.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.37. It has increased from 10.93 (Mar 24) to 11.37, marking an increase of 0.44.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.79. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 3.79, marking an increase of 0.16.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 2.89 (Mar 24) to 2.68, marking a decrease of 0.21.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.01. This value is within the healthy range. It has decreased from 5.41 (Mar 24) to 1.01, marking a decrease of 4.40.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has decreased from 4.77 (Mar 24) to 0.38, marking a decrease of 4.39.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has decreased from 4.99 (Mar 24) to 0.38, marking a decrease of 4.61.
• For PBDIT Margin (%), as of Mar 25, the value is 33.32. This value is within the healthy range. It has increased from 33.22 (Mar 24) to 33.32, marking an increase of 0.10.
• For PBIT Margin (%), as of Mar 25, the value is 23.53. This value exceeds the healthy maximum of 20. It has decreased from 26.46 (Mar 24) to 23.53, marking a decrease of 2.93.
• For PBT Margin (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 10. It has decreased from 49.53 (Mar 24) to 8.83, marking a decrease of 40.70.
• For Net Profit Margin (%), as of Mar 25, the value is 3.42. This value is below the healthy minimum of 5. It has decreased from 43.70 (Mar 24) to 3.42, marking a decrease of 40.28.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.42. This value is below the healthy minimum of 8. It has decreased from 45.68 (Mar 24) to 3.42, marking a decrease of 42.26.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 15. It has decreased from 89.09 (Mar 24) to 6.48, marking a decrease of 82.61.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.85. This value is within the healthy range. It has decreased from 16.31 (Mar 24) to 13.85, marking a decrease of 2.46.
• For Return On Assets (%), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 5. It has decreased from 15.01 (Mar 24) to 0.84, marking a decrease of 14.17.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.28. This value exceeds the healthy maximum of 1. It has increased from 1.18 (Mar 24) to 1.28, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.81. This value exceeds the healthy maximum of 1. It has increased from 1.80 (Mar 24) to 1.81, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.28. It has decreased from 0.33 (Mar 24) to 0.28, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1.5. It has increased from 0.74 (Mar 24) to 0.91, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.69 (Mar 24) to 0.88, marking an increase of 0.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.20. This value is within the healthy range. It has increased from 2.83 (Mar 24) to 3.20, marking an increase of 0.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.74. This value is below the healthy minimum of 3. It has decreased from 1.76 (Mar 24) to 1.74, marking a decrease of 0.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 505.32. It has decreased from 506.02 (Mar 24) to 505.32, marking a decrease of 0.70.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.36, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 4.08. This value is below the healthy minimum of 5. It has decreased from 4.28 (Mar 24) to 4.08, marking a decrease of 0.20.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.48, marking a decrease of 0.07.
• For Price / BV (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.48, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.81 (Mar 24) to 0.07, marking a decrease of 0.74.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness